Compare Alnylam Pharmaceuticals, Inc. (ALNY) vs Delta Air Lines, Inc. (DAL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Alnylam Pharmaceuticals, Inc. vs Delta Air Lines, Inc. — how do they compare? Alnylam Pharmaceuticals, Inc. trades at $221.5 (market cap $29.60B), while Delta Air Lines, Inc. trades at $90.38 (market cap $59.46B). The key difference: Delta Air Lines, Inc. is far larger — about 2× Alnylam Pharmaceuticals, Inc.'s market cap, and Delta Air Lines, Inc. pays a 0.86% dividend while Alnylam Pharmaceuticals, Inc. pays none. Which is the better fit depends on your goals.
| ALNY | DAL | |
|---|---|---|
Market Cap | $29.60B | $59.46B |
Sector | Health | Industrials |
52-Week High | $491.22 | $93.66 |
52-Week Low | $205.48 | $55.65 |
Enterprise Value | $27.56B | $74.77B |
Dividend Yield | — | 0.86% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia.
Read more on ALNY →About Delta Air Lines, Inc.
Atlanta-based Delta Air Lines is one of the world's largest airlines, with a network of over 300 destinations in more than 50 countries. Delta operates a hub-and-spoke system network, where it gathers and distributes passengers across the globe through key locations such as Atlanta, New York, Salt Lake City, Detroit, Seattle, and Minneapolis-St. Paul. Delta's sale of frequent flier miles, particularly to American Express, is a major driver of the firm's profits.
Read more on DAL →
